期刊文献+

急性心肌梗死患者PCI治疗后一年内发生不良心血管事件的危险因素及其预测效能

Risk factors for adverse cardiovascular events within one year after PCI treatment in patients with acute myocardial infarction and their predictive efficacy
下载PDF
导出
摘要 目的 探讨急性心肌梗死(AMI)患者经皮冠状动脉介入治疗(PCI)后一年内发生不良心血管事件(MACE)的危险因素及其预测效能。方法 AMI患者100例,均行PCI,根据治疗后一年内是否发生MACE分为MACE(+)组(14例)和MACE(-)组(86例),采用单因素分析法、多因素Cox回归分析法分析AMI患者行PCI后一年内发生MACE的影响因素和危险因素,并通过ROC曲线和Kaplan-Meier生存曲线评估危险因素的预测效能。结果 单因素分析显示,两组非经典型单核细胞亚群(NCM)比例、Genisi评分、SYNTAX评分、LVESD比较,P均<0.05。多因素分析显示,NCM比例、Genisi评分是AMI患者行PCI后一年内发生MACE的独立危险因素(P均<0.05)。ROC曲线显示,当NCM比例为9.090%时,约等指数为0.756,其预测AMI患者行PCI后一年内发生MACE的灵敏度为100%,特异度为76.5%,ROC曲线下面积为0.880,95%CI为0.812~0.947,P<0.05;Kaplan-Meier生存曲线显示,以NCM比例的最佳截断值9.090%对AMI患者进行危险分层,NCM比例≥9.090%为低危患者,NCM比例<9.090%为高危患者。结论 AMI患者行经PCI后一年内发生MACE的危险因素是NCM比例,检测此指标有助于AMI患者术后MACE事件发生的预测。 Objective To explore the risk factors for major cardiovascular adverse events(MACE)within one year after percutaneous coronary intervention(PCI)in patients with acute myocardial infarction(AMI)and their predictive effi-cacy.Methods Totally 100 AMI patients underwent PCI,and were divided into the MACE(+)group(14 cases)and MACE(-)group(86 cases)based on the occurrence of MACE within one year after treatment.Univariate analysis and multivariate Cox regression analysis were used to analyze the influencing factors and risk factors for MACE in AMI patients after PCI,and the predictive ability of risk factors was evaluated through receiver operating characteristic(ROC)curve and Kaplan-Meier survival curve.Results Univariate analysis showed that significant differences were found in the pro-portion of two non-classical monocyte subpopulations(NCM),Genisi score,SYNTAX score,and LVESD between these two groups(all P<0.05).Multivariate analysis showed that the proportion of NCM and Genisi score were independent risk factors for MACE in AMI patients after PCI(both P<0.05).The ROC curve showed that when the proportion of NCM was 9.090%,the approximate index was 0.756,with a sensitivity of 100%and a specificity of 76.5%in predicting MACE of AMI patients after PCI.The area under the ROC curve was 0.880,95%CI was 0.812 to 0.947,and P<0.05.The Ka-plan-Meier survival curve showed that AMI patients were stratified into the low-risk patients(NCM proportion≥9.090%)and high-risk patients(NCM proportion<9.090%)based on the optimal cut-off value of NCM proportion at 9.090%.Conclusion The risk factor for MACE in AMI patients after PCI within one year is the proportion of NCM,and detecting this indicator helps predict postoperative MACE in AMI patients.
作者 古力斯坦·艾斯卡尔 艾买提江·买买提 帕丽达·玉山江 吾麦尔江·克力木 米日班·玉素甫 Gulisitan Aisikaer;Aimaitijiang Maimaiti;Parida Yushanjiang;Wumai'erjiang Kelimu;Miriban Yusufu(Department of Cardiology,The Second People's Hospital of Kashgar,Kashgar 844000,China;不详)
出处 《山东医药》 CAS 2024年第24期38-42,共5页 Shandong Medical Journal
基金 新疆维吾尔自治区自然科学基金项目(2021D01F18)。
关键词 急性心肌梗死 经皮冠状动脉介入治疗 不良心管事件 非经典型单核细胞亚群比例 acute myocardial infarction percutaneous coronary intervention adverse cardiovascular events non-classical monocyte subpopulations
  • 相关文献

参考文献3

二级参考文献53

  • 1王小艳.急性冠脉综合征后6个月死亡和心肌梗死的预测:前瞻性的多国观察性研究(GRACE)[J].中国处方药,2006(11):25-26. 被引量:138
  • 2陈未,陈连凤,朱文玲,张抒扬,方全,严晓伟,汪玄,陈太波,刘震宇,谢洪智,沈珠军,高鹏,刘博江.冠心病危险因素促使人外周血单核细胞高表达尿激酶型纤溶酶原激活物受体的研究[J].中华心血管病杂志,2007,35(2):159-163. 被引量:6
  • 3Swirski FK, Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure[ J]. Science, 2013,339 (6116) :161-166. DOI: 10. l126/science. 1230719.
  • 4Ghattas A, Griffiths HR, Devitt A, et al. Monocytes in coronary artery disease and athemsclerosis: where are we now? [ J~. J Am Coil Cardiol, 2013, 62 ( 17 ) : 1541-1551. DOI: 10. 1016/ j. jacc. 2013.07. 043.
  • 5Tsujioka H, Imanishi T, Ikejima H, et al. Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction [ J ]. J Am Coil Cardiol, 2009, 54 ( 2 ) : 130-138. DOI: 10. 1016/ j. jacc. 2009. 04. 021.
  • 6Gui T, Shimokado A, Sun Y, et al. Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery[ J]. Mediators Inflamm, 2012,2012: 693083. DOI: 10. 1155/2012/693083.
  • 7Marehant DJ, Boyd JH, Lin DC, et al. Inflammation in myocardial diseases [ J ]. Circ Res, 2012, 110 ( 1 ) : 126-144. DOI: 10. ll61/CIRCRESAHA. 111. 243170.
  • 8Ma L, Zhou Z, Zhang D, et al. Immunosuppressive fimetion of mesenchymal stem cells from human umbilical cord matrix in immune thromboeytopenia patients [ J ]. Thromb Haemost, 2012, 107(5) :937-950. DOI: 10. 1160/THl1-08-0596.
  • 9van den Akker F, Deddens JC, Doevendans PA, et al. Cardiac stem cell therapy to modulate inflammation upon myocardial infarction[ J ]. Biochim Biophys Acta, 2013,1830 ( 2 ) : 2449- 2458. DOI: 10. 1016/j. bbagen. 2012. 08. 026.
  • 10Yona S, Kim KW, Wolf Y, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis [ J ] . Immunity, 2013, 38 ( 1 ) : 79-91. DOI: 10. lO16/j, immuni. 2012. 12. 001.

共引文献1885

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部